Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study
NCT ID: NCT02000011
Last Updated: 2022-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2014-05-23
2022-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We propose to perform a prospective and randomized study to evaluate the impact of a CGA with GIP in 70 years old and more patients with a thoracic, digestive or urologic cancer resection, respectively 1, 3, 6 and 12 months after discharge. CGA and GIP will focus on 8 distinct fields: autonomy, co-morbidities, co-medication, mobility, nutritional status, depression, cognitive function and social status. The impact of such a strategy on autonomy and survival has never been studied.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastric Cancer Surgery in Elderly Patients
NCT03777540
Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over
NCT03077178
Care Pathways and Disparities in Care for Older Patients With Cancer: Typology, Determinants and Effect on Prognosis ( PASSAGE )
NCT07092800
Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery
NCT03299270
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
NCT06589414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard strategy
comprehensive geriatric assessment (CGA)
experimental strategy
comprehensive geriatric assessment (CGA)
Geriatric intervention plan (GIP)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comprehensive geriatric assessment (CGA)
Geriatric intervention plan (GIP)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a resectable cancer( thoracic, digestive ore urologic);
* Patients who have to undergo a surgery with general anaesthesia;
* Patients treated in one of the partner programme unit ;
* Patient able to fill in an auto-questionnaire alone or with some help;
* Patient who have signed an informed consent and who commits himself or herself to respect the protocol instructions.
Exclusion Criteria
* Patient who is not registered to the social ;
* Patient for whom surgery is performed under local anaesthesia;
* Patient unable to fill-in alone an autoquestionnaire (because of an inability to read French language or severe cognitive troubles);
* Patient treated with neuroleptic or lithium ;
* Patient with already known cognitive impairment (Alzheimer, dementia, neurologic sequel);
* Patient under legal protection;
* Patient who has not signed informed consent.
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LOIC MONDOLONI
Role: STUDY_DIRECTOR
Assistance Publique Hopitaux De Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-33
Identifier Type: OTHER
Identifier Source: secondary_id
2013-A01038-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.